Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Margreet A. Veening"'
Autor:
Kirsten A. Thus, Hester A. de Groot-Kruseman, Pauline Winkler-Seinstra, Marta Fiocco, Heidi Segers, Cor van den Bos, Inge M. van der Sluis, Wim J.E. Tissing, Margreet A. Veening, Christian Michel Zwaan, Cornelis M. van Tilburg, Rob Pieters, Marc Bierings
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Infections lead to substantial morbidity during treatment of acute lymphoblastic leukemia (ALL) in which the adaptive immune system gets severely affected, leading to declining serum immunoglobulin levels. The aim of this trial was to investigate whe
Externí odkaz:
https://doaj.org/article/634bb1c123c8458d9d413f68bd657421
Autor:
Emma Kroeze, Michelle M. Kleisman, Lennart A. Kester, Marijn A. Scheijde‐Vermeulen, Edwin Sonneveld, Jessica G. C. Buijs‐Gladdines, Melanie M. Hagleitner, Friederike A. G. Meyer‐Wentrup, Margreet A. Veening, Auke Beishuizen, Jules P. P. Meijerink, Jan L. C. Loeffen, Roland P. Kuiper
Publikováno v:
HemaSphere, Vol 8, Iss 7, Pp n/a-n/a (2024)
Abstract Twenty percent of children with T‐cell lymphoblastic lymphoma (T‐LBL) will relapse and have an extremely poor outcome. Currently, we can identify a genetically low‐risk subgroup in pediatric T‐LBL, yet these high‐risk patients who
Externí odkaz:
https://doaj.org/article/f691a15ba3c94664ba8c567a4dea1811
Autor:
Katja I. Braam, Elisabeth M. van Dijk-Lokkart, Gertjan J. L. Kaspers, Tim Takken, Jaap Huisman, Laurien M. Buffart, Marc B. Bierings, Johannes H. M. Merks, Marry M. van den Heuvel-Eibrink, Margreet A. Veening, Eline van Dulmen-den Broeder
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background Physical fitness and psychosocial function is often reduced in children during or shortly after cancer treatment. This study evaluates the effect of a combined physical exercise and psychosocial intervention on cardiorespiratory f
Externí odkaz:
https://doaj.org/article/beed8505f08d45beb9195e8a8ba23e79
Autor:
Jeanine J. Sol, Moniek van de Loo, Marit Boerma, Klasien A. Bergman, Albertine E. Donker, Mark A. H. B. M. van der Hoeven, Christiaan V. Hulzebos, Ronny Knol, K. Djien Liem, Richard A. van Lingen, Enrico Lopriore, Monique H. Suijker, Daniel C. Vijlbrief, Remco Visser, Margreet A. Veening, Mirjam M. van Weissenbruch, C. Heleen van Ommen
Publikováno v:
BMC Pediatrics, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background In critically ill (preterm) neonates, central venous catheters (CVCs) are increasingly used for administration of medication or parenteral nutrition. A serious complication, however, is the development of catheter-related thrombos
Externí odkaz:
https://doaj.org/article/c6323bcb11814dc990c1d9a60e71cc41
Autor:
M E Madeleine van der Perk, Anne-Lotte L F van der Kooi, Marianne D van de Wetering, Irene M IJgosse, Eline van Dulmen-den Broeder, Simone L Broer, Aart J Klijn, A Birgitta Versluys, Brigitte Arends, Ralph J A Oude Ophuis, Hanneke M van Santen, Alida F W van der Steeg, Margreet A Veening, Marry M van den Heuvel-Eibrink, Annelies M E Bos
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0246344 (2021)
BackgroundChildhood cancer patients often remain uninformed regarding their potential risk of gonadal damage. In our hospital we introduced a five step standard oncofertility care plan for all newly diagnosed female patients aiming to identify, infor
Externí odkaz:
https://doaj.org/article/630e755248784d3da100940d2c764740
Autor:
Esmee C.M. Kooijmans, Helena J.H. van der Pal, Saskia M.F. Pluijm, Dorine Bresters, Eline van Dulmen-den Broeder, Margriet van der Heiden-van der Loo, Marry M. van den Heuvel-Eibrink, Leontien C.M. Kremer, Jacqueline J. Loonen, Marloes Louwerens, Sebastian J.C. Neggers, Maxime Pilon, Cécile Ronckers, Wim J.E. Tissing, Andrica C.H. de Vries, Gertjan J.L. Kaspers, Arend Bökenkamp, Margreet A. Veening
Publikováno v:
Dutch LATER study group 2022, ' Hypertension in long-term childhood cancer survivors after treatment with potentially nephrotoxic therapy; DCCSS-LATER 2 : Renal study ', European Journal of Cancer, vol. 172, pp. 287-299 . https://doi.org/10.1016/j.ejca.2022.05.038
European Journal of Cancer, 172, 287-299. ELSEVIER SCI LTD
European Journal of Cancer, 172, 287-299. Elsevier Ltd.
European Journal of Cancer, 172, pp. 287-299
European Journal of Cancer, 172, 287-299. Pergamon
European Journal of Cancer, 172, 287-299. Elsevier Limited
European Journal of Cancer, 172, 287-299
European Journal of Cancer, 172, 287-299. ELSEVIER SCI LTD
European Journal of Cancer, 172, 287-299. Elsevier Ltd.
European Journal of Cancer, 172, pp. 287-299
European Journal of Cancer, 172, 287-299. Pergamon
European Journal of Cancer, 172, 287-299. Elsevier Limited
European Journal of Cancer, 172, 287-299
Purpose: To evaluate the prevalence of and risk factors for hypertension in childhood cancer survivors (CCSs) who were treated with potentially nephrotoxic therapies.Methods: In the Dutch Childhood Cancer Survivor Study LATER cohort part 2 renal stud
Autor:
Katja C E Drechsel, Maxime C F Pilon, Francis Stoutjesdijk, Salena Meivis, Linda J Schoonmade, William Hamish B Wallace, Eline van Dulmen-den Broeder, Auke Beishuizen, Gertjan J L Kaspers, Simone L Broer, Margreet A Veening
Publikováno v:
Human Reproduction Update.
BACKGROUNDOwing to a growing number of young and adolescent Hodgkin lymphoma (HL) survivors, awareness of (long-term) adverse effects of anticancer treatment increases. The risk of impaired reproductive ability is of great concern given its impact on
Publikováno v:
Kidney International, 103(1), 227-228. Nature Publishing Group
the Dutch LATER study group 2023, ' Letter to the Editor ', Kidney International, vol. 103, no. 1, pp. 227-228 . https://doi.org/10.1016/j.kint.2022.11.003
the Dutch LATER study group 2023, ' Letter to the Editor ', Kidney International, vol. 103, no. 1, pp. 227-228 . https://doi.org/10.1016/j.kint.2022.11.003
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::495a6cfee305258fad9d9f341e085d9d
https://research.vumc.nl/en/publications/88e112ac-575d-4a6b-8848-f754bfced095
https://research.vumc.nl/en/publications/88e112ac-575d-4a6b-8848-f754bfced095
Autor:
Eline A. M. Zijtregtop, Claudius Diez, C. Michel Zwaan, Margreet A. Veening, Auke Beishuizen, Friederike A. G. Meyer‐Wentrup
Publikováno v:
British Journal of Haematology, 200(1), 70-78. Wiley-Blackwell Publishing Ltd
British Journal of Haematology, 200(1), 70-78. Wiley-Blackwell
Zijtregtop, E A M, Diez, C, Zwaan, C M, Veening, M A, Beishuizen, A & Meyer-Wentrup, F A G 2023, ' Thymus and activation-regulated chemokine (TARC) as treatment response marker for paediatric Hodgkin lymphoma : A pilot study ', British Journal of Haematology, vol. 200, no. 1, pp. 70-78 . https://doi.org/10.1111/bjh.18473
British Journal of Haematology, 200(1), 70-78. Wiley-Blackwell
Zijtregtop, E A M, Diez, C, Zwaan, C M, Veening, M A, Beishuizen, A & Meyer-Wentrup, F A G 2023, ' Thymus and activation-regulated chemokine (TARC) as treatment response marker for paediatric Hodgkin lymphoma : A pilot study ', British Journal of Haematology, vol. 200, no. 1, pp. 70-78 . https://doi.org/10.1111/bjh.18473
Classical Hodgkin lymphoma (cHL) is characterised by malignant Hodgkin Reed-Sternberg cells located in an inflammatory microenvironment. Blood biomarkers result from active cross-talk between malignant and non-malignant cells. One promising biomarker
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fdcca7e57810a9cc92333a06a821902
https://pure.eur.nl/en/publications/d89e960d-18a5-4c98-8aba-324b1b6ed3e1
https://pure.eur.nl/en/publications/d89e960d-18a5-4c98-8aba-324b1b6ed3e1
Autor:
Riccardo Haupt, Clarisa R. Gracia, Gabriele Calaminus, Jacqueline J. Loonen, Isabelle Demeestere, Kirsi Jahnukainen, Leontien C. M. Kremer, Barbara A. Lockart, Hanneke M van Santen, Karen Burns, Wim J. E. Tissing, Richard N. Yu, Eva Maria Tinner, Louis S. Constine, Thorsten Langer, Ogechukwu A Asogwa, W. Hamish B. Wallace, Sebastian J C M M Neggers, Erik A. H. Loeffen, Marianne D. van de Wetering, Sarah E Hunter, Margreet A. Veening, Lisa B. Kenney, Julianne Byrne, Claire Berger, Joanne Frankel Kelvin, Natascia Di Iorgi, Roderick Skinner, Ans M M van Pelt, Daniel M. Green, Richard A Anderson, Holly R. Hoefgen, Marij Dinkelman-Smit, Herman Tournaye, Eveline Stutz-Grunder, Marleen van de Berg, Andreas Ranft, Chris M Verhaak, Christian Denzer, Andrica de Vries, Kenny A. Rodriguez-Wallberg, Michelle Peate, Lillian R. Meacham, Joop S.E. Laven, Renée L. Mulder, Rejin Kebudi, Cornelis B. Lambalk, Anna Font-Gonzalez, Norbert W Paul, Jennifer Levine, Rod T. Mitchell, Catharyn Stern, Eline van Dulmen-den Broeder, Tamara Diesch, James L. Klosky, Antoinette Anazodo, Armando Lorenzo, Annelies M E Bos, Desiree Grabow, Wendy van Dorp, Andreas Meissner, Uta Dirksen, Gwendolyn P. Quinn, Melissa M. Hudson, Bob Phillips, Damon R. Reed, Aleksander Giwercman, Julia Inthorn, Marry M. van den Heuvel-Eibrink, J. D. Beck, Leena Nahata, Alexandra Brownsdon, Peter Kaatsch, Anke Barnbrock, Jill P. Ginsberg
Publikováno v:
PanCareLIFE Consortium 2021, ' Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer : recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group ', The Lancet Oncology, vol. 22, no. 2, pp. e68-e80 . https://doi.org/10.1016/S1470-2045(20)30595-7
The Lancet Oncology, 22(2), e68-e80. Lancet Publishing Group
The Lancet Oncology, 22(2), e68-e80. Lancet Publishing Group
Patients with childhood, adolescent, and young adult cancer who will be treated with gonadotoxic therapies are at increased risk for infertility. Many patients and their families desire biological children but effective communication about treatment-